Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
InMode (DE:154)
FRANKFURT:154
Holding DE:154?
Track your performance easily
154 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€13.51 - €24.76
Previous Close€17.29
Volume0.00
Average Volume (3M)310.00
Market Cap
€1.54B
Enterprise Value€847.50M
Total Cash (Recent Filing)$741.61M
Total Debt (Recent Filing)$2.40M
Price to Earnings (P/E)―
Beta0.95
Next Earnings
Feb 06, 2025EPS Estimate
€0.55Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding83,982,462
10 Day Avg. Volume10
30 Day Avg. Volume310
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)1.76
Price to Sales (P/S)3.02
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.61
Enterprise Value/Gross Profit2.06
Enterprise Value/Ebitda8.21
Forecast
1Y Price Target
€20.63Price Target Upside19.31% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
InMode News
PremiumCompany Announcements
InMode’s Q3 2024: Revenue Growth Amid Challenges
PremiumCompany Announcements
InMode Sees Revenue Growth Amidst Challenges in Q3 2024
Bulls Say, Bears Say
Bulls Say
Financial PerformanceINMD's balance sheet position allows it to think long-term beyond this downturn.
Market ExpansionMarkets outside the U.S. still represent a large and growing opportunity for medical aesthetics while adoption of adjacent platform technologies in gynecology and ophthalmology remain in the early innings.
Product InnovationRecently launched products could 'ignite' new capital cycle with innovations like IgniteRF and Optimas Max, which offer significant clinical enhancements and time-savings.
Bears Say
Financial PerformanceINMD's gross margin was down 220 basis points year-over-year and operating margin was down 290 basis points year-over-year.
Management And Organizational ChallengesSweeping management changes add another layer of complexity to the story; maintain HOLD.
Market Demand And Economic OutlookGlobal aesthetic demand clearly remains pressured, as 3Q pro-forma revenue declined 20% y/y and management again lowered full-year guidance.
---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
9.83% Mutual Funds
23.71% Other Institutional Investors
59.87% Public Companies and
Individual Investors
154 FAQ
What was InMode’s price range in the past 12 months?
InMode lowest stock price was €13.51 and its highest was €24.76 in the past 12 months.
What is InMode’s market cap?
Currently, no data Available
When is InMode’s upcoming earnings report date?
InMode’s upcoming earnings report date is Feb 06, 2025 which is in 75 days.
How were InMode’s earnings last quarter?
InMode released its earnings results on Oct 30, 2024. The company reported €0.66 earnings per share for the quarter, beating the consensus estimate of €0.535 by €0.125.
Is InMode overvalued?
According to Wall Street analysts InMode’s price is currently Undervalued.
Does InMode pay dividends?
InMode does not currently pay dividends.
What is InMode’s EPS estimate?
InMode’s EPS estimate is €0.55.
How many shares outstanding does InMode have?
InMode has 84,619,120 shares outstanding.
What happened to InMode’s price movement after its last earnings report?
InMode reported an EPS of €0.66 in its last earnings report, beating expectations of €0.535. Following the earnings report the stock price went down -0.392%.
Which hedge fund is a major shareholder of InMode?
Among the largest hedge funds holding InMode’s share is Deerfield Management Company, LP. It holds InMode’s shares valued at 27M.
---
InMode Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€20.63 (19.31% Upside)
€20.63 (19.31% Upside)
Blogger Sentiment
Bullish
DE:154 Sentiment 80%
Sector Average 71%
Sector Average 71%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-17.98%
12-Months-Change
Fundamentals
Return on Equity
21.04%
Trailing 12-Months
Asset Growth
3.84%
Trailing 12-Months
Company Description
InMode
InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. It also designs, develops, manufactures and markets non-invasive medical aesthetic products that target a array of procedures including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture and superficial benign vascular and pigmented lesions. The company was founded by Moshe Mizrahy and Michael Kreindel on January 2, 2008 and is headquartered in Yokneam, Israel.
---
154 Company Deck
---
154 Earnings Call
Q3 2024
0:00 / 0:00
---
154 Stock 12 Month Forecast
Average Price Target
€20.63
▲(19.31% Upside)
Technical Analysis
Best Analysts Covering 154
1 Year
1 Year Success Rate
13/29 ratings generated profit
1 Year Average Return
+10.70%
reiterated a buy rating last month
Copying Jeff Johnson's trades and holding each position for 1 Year would result in 44.83% of your transactions generating a profit, with an average return of +10.70% per trade.
---